Matches in Nanopublications for { ?s ?p "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP865223.RAAr3dJvdwca-kqzTZfteI5bU_zx0gmrvCeL9EBfcneg4130_assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865223.RAAr3dJvdwca-kqzTZfteI5bU_zx0gmrvCeL9EBfcneg4130_provenance.
- NP646238.RAJ1oPVAvJlg9uzhpczjFsArsAhvBU4M3SBVeKR0Uv6Ec130_assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646238.RAJ1oPVAvJlg9uzhpczjFsArsAhvBU4M3SBVeKR0Uv6Ec130_provenance.
- NP664381.RALuaMzL6xZm2XVOG1-NJqRs0o-0kG33zh4u_L4coYcQ4130_assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664381.RALuaMzL6xZm2XVOG1-NJqRs0o-0kG33zh4u_L4coYcQ4130_provenance.
- NP946590.RAY-RJgpygj12pzBV3goTTWkW8NythqM5xZnjtCAXxETQ130_assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946590.RAY-RJgpygj12pzBV3goTTWkW8NythqM5xZnjtCAXxETQ130_provenance.
- assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP946586.RAInPXa-lyELw5Grn91K-m4q9G7HfxOG7aJ1hywSdh1jk130_assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946586.RAInPXa-lyELw5Grn91K-m4q9G7HfxOG7aJ1hywSdh1jk130_provenance.
- NP946587.RAN26XiXWllt6lS6cqSg_LqxsFZF0fR9j2eu74gB2KDLc130_assertion description "[Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946587.RAN26XiXWllt6lS6cqSg_LqxsFZF0fR9j2eu74gB2KDLc130_provenance.